# Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

> **NCT06910514** · PHASE3 · COMPLETED · sponsor: **Nakafarma S.L.** · enrollment: 52 (actual)

## Conditions studied

- Endoscopic Mucosal Resection
- Colonic Neoplasms
- Therapeutic Irrigation
- Treatment Outcome

## Interventions

- **COMBINATION_PRODUCT:** Mucopolysaccharide saline solution 0.9%
- **COMBINATION_PRODUCT:** Saline solution 0.9%

## Key facts

- **NCT ID:** NCT06910514
- **Lead sponsor:** Nakafarma S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-18
- **Primary completion:** 2022-12-23
- **Final completion:** 2022-12-23
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06910514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06910514, "Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06910514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*